Only in May 2008, did the administration finally back down from its unconditional defense of the policy. After the head of the Sexual Misconduct Office, Charlene Allen, indignantly resigned earlier that month, the administration was forced to go public with their attempts to revise the policy in secret.
Every time a successful treatment was found the results were ‘rubbished’ or ignored by the pharmacartel that controls ‘medicine’ to this day: A few examples: Paris Medical Gazette 1845 in 1834 a lady was given amygdalin (now known as B17 or Laetrile, see later notes) and was still surviving at the time of the...